mortality/aging
• all mice infected with murine hepatitis virus strain 1 (MHV-1)
|
• mice infected with the mouse-adapted H1N1 influenza A virus, PR8 strain,
|
immune system
• SARS-CoV-MA15-infected mice show lower levels of CD8 and CD4 T cell apoptos
|
• SARS-CoV-MA15-infected mice show increased numbers of virus-specific CD4 T cells in lungs
|
• SARS-CoV-MA15-infected mice show increased numbers of virus-specific CD8 T cells in lungs
|
• SARS-CoV-MA15-infected mice do show an increase in highly activated inflammatory monocyte-macrophages as is seen in infected BALB/c controls
• SARS-CoV-MA15-infected mice show a decrease in the percentage and numbers of inflammatory monocyte-macrophages that produce the pro-inflammatory cytokines TNF, IL-6, IL1-beta, and iNOS
|
• SARS-CoV-MA15-infected mice do not show an increase in Ly6ChiCD11b+ cells in the lungs as is seen in controls
|
• SARS-CoV-MA15- infected mice have reduced levels of cytokines and chemokines in the broncho-alveolar lavage fluid
|
• all mice infected with murine hepatitis virus strain 1 (MHV-1)
|
• mice infected with the mouse-adapted H1N1 influenza A virus, PR8 strain,
|
• mice infected with a lethal dose of the mouse adapted severe acute respiratory syndrome coronavirus (SARS-CoV-MA15)
• middle-aged (8-9 month old) mice show increased survival after SARS-CoV-MA15 infection compared to middle-aged BALB/c control mice
• total lung virus loads after SARS-CoV-MA15 infection are the same as in control mice, except for a modest increase at 3 days post infection (dpi) in mutants
• SARS-CoV-MA15 virus is completely cleared from the lungs by 10 dpi
• SARS-CoV-MA15-infected mice show nearly normal lungs at 3 and 5 dpi compared to hyperemia and congestion in controls, with minimal alveolar edema and increased peribronchial-perivascular immune cell infiltration, and reduced lung microvascular leakage
|
homeostasis/metabolism
• SARS-CoV-MA15- infected mice have reduced levels of cytokines and chemokines in the broncho-alveolar lavage fluid
|
hematopoietic system
• SARS-CoV-MA15-infected mice show lower levels of CD8 and CD4 T cell apoptos
|
• SARS-CoV-MA15-infected mice show increased numbers of virus-specific CD4 T cells in lungs
|
• SARS-CoV-MA15-infected mice show increased numbers of virus-specific CD8 T cells in lungs
|
• SARS-CoV-MA15-infected mice do show an increase in highly activated inflammatory monocyte-macrophages as is seen in infected BALB/c controls
• SARS-CoV-MA15-infected mice show a decrease in the percentage and numbers of inflammatory monocyte-macrophages that produce the pro-inflammatory cytokines TNF, IL-6, IL1-beta, and iNOS
|
• SARS-CoV-MA15-infected mice do not show an increase in Ly6ChiCD11b+ cells in the lungs as is seen in controls
|
cellular
• SARS-CoV-MA15-infected mice show lower levels of CD8 and CD4 T cell apoptos
|